These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Diagnosis
14 results:

  • 1. [A Case of BRAF V600E-Mutant colorectal cancer Treated Effectively by Encorafenib, Binimetinib, and Cetuximab Triple Therapy].
    Sakamoto S; Tagai N; Shimada M; Kurebayashi H; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
    Gan To Kagaku Ryoho; 2022 Oct; 49(10):1145-1147. PubMed ID: 36281614
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in colorectal cancer via Epigenetically Silencing TPM1.
    Li C; Hong S; Hu H; Liu T; Yan G; Sun D
    Mol Cancer Res; 2022 Nov; 20(11):1697-1708. PubMed ID: 35857351
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes.
    Houvenaeghel G; de Nonneville A; Blache G; Buttarelli M; Jauffret C; Mokart D; Sabiani L
    J Gynecol Oncol; 2022 May; 33(3):e31. PubMed ID: 35320883
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal cancer].
    Tsujio G; Muguruma K; Eguchi S; Iseki Y; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Nagahara H; Toyokawa T; Tanaka H; Lee S; Yashiro M; Ohira M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2073-2075. PubMed ID: 35045497
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of new cancer therapies on outpatient treatment delivery for colorectal cancer: A population-based study.
    Chen L; Speers CH; Cheung WY; Spinelli JJ; Kennecke HF
    Int J Health Plann Manage; 2022 Jan; 37(1):258-270. PubMed ID: 34545610
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [A Case of Submucosal-Like Tumor at Cecum That Was Diagnosed as Colon Metastasis from Gastric cancer].
    Okazaki Y; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Wang E; Maeda K; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2343-2345. PubMed ID: 33468955
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
    López-Sánchez LM; Jiménez-Izquierdo R; Peñarando J; Mena R; Guil-Luna S; Toledano M; Conde F; Villar C; Díaz C; Ortea I; De la Haba-Rodríguez JR; Aranda E; Rodríguez-Ariza A
    J Cell Mol Med; 2019 Dec; 23(12):8219-8232. PubMed ID: 31560832
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ultrasound triggered phase-change nanodroplets for doxorubicin prodrug delivery and ultrasound diagnosis: An in vitro study.
    Gao J; Yu B; Li C; Xu M; Cao Z; Xie X; Wang W; Liu J
    Colloids Surf B Biointerfaces; 2019 Feb; 174():416-425. PubMed ID: 30481702
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [A Case of Sigmoid Colon cancer with Metastasis to the Uterus].
    Tokoro Y; Tonooka T; Souda H; Takiguchi N; Chibana T; Kobayashi R; Arimitsu H; Yanagibashi H; Chou A; Ikeda A; Nabeya N; Kainuma O; Yamamoto H; Nagata M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1662-4. PubMed ID: 26805130
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
    Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
    Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Changing practices for diagnosis and treatment of colorectal cancer in Calvados: 1990-1999.
    Bouhier K; Maurel J; Lefevre H; Bouin M; Arsène D; Launoy G
    Gastroenterol Clin Biol; 2004 Apr; 28(4):371-6. PubMed ID: 15146153
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Implications of genetic testing in the management of colorectal cancer.
    Stoehlmacher J; Lenz HJ
    Am J Pharmacogenomics; 2003; 3(2):73-88. PubMed ID: 12749725
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Detection of malignancy-associated metabolites in the sera of cancer patients by electron capture gas chromatography.
    Brooks JB; Almenoff PL; Daneshvar MI; Johnson AH; Spechart VJ; Basta MT; Unger SE; King JN; Schwartz B
    Br J Cancer; 1994 Apr; 69(4):655-62. PubMed ID: 8142254
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Usefulness of the determination of carcinoembryonic antigen (CEA) in the serum of patients with colorectal cancer in Albania.
    Leskoviku S; Lasku A; Marku N; Rada F; Dibra A
    Panminerva Med; 1992; 34(4):168-71. PubMed ID: 1293545
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.